← Back to all earnings calls

Avalo Therapeutics, Inc. Q3 FY2021 Earnings Call

Avalo Therapeutics, Inc. (AVTX)

Earnings Call FY2021 Q3 Call date: 2021-11-09 Concluded

Share

Quarter scorecard

Revenue

$1.35M

+21.5% YoY

Net income

$

Revenue · products & services

Product $1.35M

+21.5%

License $

Documents & deck